Abstract | BACKGROUND:
Bleeding irregularities represent the most common etonogestrel subdermal implant (ESI) removal indication. STUDY DESIGN: ESI placements (n=304) from June 2007 to April 2011 were grouped by removal indications. Group characteristics were compared using one-way analysis of variance, Kruskal-Wallis and χ(2) test. RESULTS: Of 304 insertions, 30.6% reported irregular bleeding. Removal indications included bleeding (Group 1, n=50), side effects (Group 2, n=17) and desired pregnancy/no need (Group 3, n=25). Group 4 kept (n=198) or reinserted (n=14) ESI. Median body mass index was lower for Group 1 compared to other groups (p=.012). Group 3 was older than Group 1 or 4 (p=.021), and more likely parous (p<.001) and postpartum (p=.001) than other groups. Lactational placement was more common in Group 3 than 4 (p<.001). Obese women were 2.6 times less likely to remove ESI for bleeding vs. normal-weight or overweight women (95% confidence interval, 1.2-5.7; p=.014). CONCLUSIONS: After adjusting for age and parity, obese women were less likely to have ESI removal for bleeding.
|
Authors | Petra M Casey, Margaret E Long, Mary L Marnach, Jennifer Fleming-Harvey, Linda B Drozdowicz, Amy L Weaver |
Journal | Contraception
(Contraception)
Vol. 87
Issue 3
Pg. 370-4
(Mar 2013)
ISSN: 1879-0518 [Electronic] United States |
PMID | 22959901
(Publication Type: Journal Article)
|
Copyright | Copyright © 2013 Elsevier Inc. All rights reserved. |
Chemical References |
- Contraceptive Agents, Female
- etonogestrel
- Desogestrel
|
Topics |
- Adolescent
- Adult
- Body Mass Index
- Contraceptive Agents, Female
(administration & dosage, adverse effects)
- Desogestrel
(administration & dosage, adverse effects)
- Device Removal
(statistics & numerical data)
- Female
- Humans
- Menstruation Disturbances
(chemically induced)
- Middle Aged
- Retrospective Studies
- Uterine Hemorrhage
(chemically induced)
- Young Adult
|